Ascendis Pharma AS (ASND) Stock Price, Quote, News & History

ASNDNASDAQ
$225.60
-5.10-2.21%
At close: Sep 25, 5:00 PM EST
$225.60
N/A
After Hours: Sep 25, 4:30 PM EST

Ascendis Pharma (ASND) Stock Price, Quote, News & History | Benzinga

60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
349.51M
Investing Cash Flow (TTM)
-13.05M
Financing Cash Flow (TTM)
-35.58M
Free Cash Flow (TTM)
335.12M
Capital Expenditure (TTM)
-14.39M
Net Change in Cash (TTM)
300.88M

Analyst Trends and Forecast

2
Apr
4
May
2
Jul
9
Aug
4
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$14.44B
PE Ratio (TTM)
18.01
PE Ratio (FWD)
20.53
PEG Ratio (TTM)
-
PS Ratio (TTM)
12.19
PB Ratio (TTM)
9.23
Earnings Yield % (TTM)
5.55%
Earnings Yield % (FWD)
4.87%
EV / EBITDA (TTM)
68.04
Price / EBITDA (TTM)
66.94
Price / Free Cash Flow (TTM)
38.08
Book Value / Share
$25.00

Company Debt

Total Debt
$450.07M
LT Debt
$384.64M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$30.13M
Total Cash
$812.26M
Debt to Equity
0.31
Issuance of Debt (TTM)
-$30.13M
Repayment of Debt (TTM)
-$30.13M

Key Statistics

Open
$230.13
Close
$225.60
Volume / Avg.
419.97K / 731.10K
Day Range
$224.26 - $230.43
52 Wk Range
186.05 - 282.15
Market Cap
$14.84B
P/E Ratio
18.01
Dividend Yield
-
Exchange
NASDAQ
RSI
35
Short Interest
7.13%
Days to Cover
4.9

About

Sector
Health Care
Industry
Biotechnology
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Ascendis Pharma (ASND) stock?

A

You can purchase shares of Ascendis Pharma (NASDAQ:ASND) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Ascendis Pharma (ASND) competitors?

Q

What is the forecast, or price target, for Ascendis Pharma (ASND) stock?

A

Ascendis Pharma has a consensus price target of $299.48.

Q

What is the current price for Ascendis Pharma (ASND)?

A

The stock price for Ascendis Pharma (NASDAQ: ASND) is $225.6 last updated September 25, 2026 at 4:30 PM EDT.

Q

Does Ascendis Pharma (ASND) pay a dividend?

A

There are no upcoming dividends for Ascendis Pharma.

Q

When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?

A

Ascendis Pharma does not have any upcoming earnings scheduled.

Q

Is Ascendis Pharma (ASND) going to split?

A

There is no upcoming split for Ascendis Pharma.

Q

What sector and industry does Ascendis Pharma (ASND) operate in?

A

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.